LUCD earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -2.03. Updated 2026-07-23.
Lucid Diagnostics (LUCD) Research Hub
Lucid Diagnostics (LUCD) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 0.7829 USD (-4.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.03, market cap 0.10B. This hub links to the full technical, earnings and options research available for LUCD.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.7829 USD (-4.65%) |
| 52-week range | 0.78 USD – 1.23 USD |
| Trend regime | Range |
| 14-day RSI | 27.8 (Oversold) |
| Trailing P/E | -2.03 |
| Market cap | 0.10B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for LUCD
Covered Call on LUCD: how it works, illustrative setup around the real 0.7829 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LUCD: how it works, illustrative setup around the real 0.7829 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LUCD: how it works, illustrative setup around the real 0.7829 USD price, max profit/loss, breakeven and when to use it. Educational.
LUCD technical analysis: range, last 0.7829 USD, RSI 27.8, 52w range 0.78 USD–1.23 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LUCD in?
Lucid Diagnostics (LUCD) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is LUCD in an uptrend or downtrend?
As of 2026-09-11, LUCD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LUCD's trailing P/E ratio?
LUCD's trailing P/E is -2.03, with a market cap of 0.10B. See the earnings research page for full valuation detail.
When does LUCD next report earnings?
LUCD is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.04 USD.